Since 1990, Stragen has always been committed to the development of Selected and Advanced Generics

As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we constantly aim at improving the existing therapeutics by offering:

  • Niche molecules
  • Hard-to-make drugs
  • Innovative delivery forms to improve health daily practices
Rx products

Therapeutic Areas

No products were found matching the selected filters
Rx-products Gynaecology Gesdonyl-20


Ethinylestradiol 20 µg / Gestodene 75 µg

Rx-products Gynaecology Daisynelle

Ridne® 35

Ethinylestradiol 35 µg / Cyproterone acetate 2 mg